Glioma: all 1,425 studies
Page 3 of 15. Open to participants first (355), then studies with results posted, then the rest; newest registration first within each.
- Study of Olutasidenib and Temozolomide in HGGRecruitingNCT06161974Phase 2
- Recurrent High Grade Glioma Treated by LITTRecruitingNCT06161610Not applicable
- PLX038 in Primary Central Nervous System Tumors Containing MYC or MYCN AmplificationsRecruitingNCT06161519Phase 1/2
- Phase III Clinical Trial Evaluating the Resection Efficacy of 5-Aminolevulinic Acid Hydrochloride (5-ALA HCl) Fluorescence-Guided Microsurgery Versus Conventional White Light Microsurgery in Patients With Malignant Glioma (WHO Grade 3/4)RecruitingNCT06160492Phase 3
- Binimetinib in Patients With BRAF Fusion-positive Low-grade Glioma or Pancreatic Cancer (Perfume)RecruitingNCT06159478Phase 2
- The Role of B7-H4 in Tumor VaccineRecruitingNCT06156150
- Open-Label Study to Evaluate the Safety, Tolerability and Efficacy of the Oncolytic HSV1 MVR-C5252RecruitingNCT06126744Phase 1
- The SUPRAMAX Study: Supramaximal Resection Versus Maximal Resection for High-Grade Glioma Patients (ENCRAM 2201)RecruitingNCT06118723
- Clinical Relevance of Detecting Molecular Abnormalities in Glial Tumor ExosomesRecruitingNCT06116903Not applicable
- Tumor Vaccines for Solid TumorsRecruitingNCT06102837
- Development of MRF for Characterization of Brain Tumors After RadiotherapyRecruitingNCT06101069Not applicable
- Supportive Psychoeducational Intervention for Patients With Brain Tumors (Acceptance and Commitment Therapy-based Supportive Intervention for Patients With Central Nervous System Tumors)RecruitingNCT06099743Not applicable
- RE-irradiation of Diffuse MIdline Glioma paTientsNot yet recruitingNCT06093165Not applicable
- A Phase 0/1 Study of BDTX-1535 in Recurrent High-Grade Glioma (rHGG) and Newly Diagnosed Glioblastoma (nGBM) Participants With EGFR Alterations or FusionsRecruitingNCT06072586Early Phase 1
- Use of Pulsed Low-dose Rate Re-irradiation for Recurrent Glioma (PULSAR)RecruitingNCT06055517Not applicable
- Reducing Cognitive Impairment in Glioma with Repetitive Transcranial Magnetic Stimulation and Cognitive Strategy TrainingRecruitingNCT06043765Not applicable
- MMR/MSI Phenotypes in Prediction of Tumor Vaccine Benefit for GliomasRecruitingNCT06043232
- Spatial and Temporal Characterization of Gliomas Using Radiomic AnalysisRecruitingNCT06036381
- A Study of Chlorophyllin for the Management of Brain Radio-necrosis in Patients With Diffuse GliomaRecruitingNCT06016452Phase 2
- Multi-Dimensional MRI Spatial Heterogeneity Analysis for Predicting Key Genes and Prognosis of High-Grade Gliomas: A Multi-Center StudyRecruitingNCT06002711
- MCT for the Harvard/UCSF ROBIN CenterRecruitingNCT06000787Not applicable
- CEST in Low-grade Glioma StudyRecruitingNCT05996653Not applicable
- Magnetic Resonance Elastography in Glioma: Exploring Tumor Stiffness and AdhesionRecruitingNCT05990244Not applicable
- Omental Tissue Autograft in Human Recurrent Glioblastoma Multiforme (rGBM)RecruitingNCT05979064Not applicable
- NeuroPathways Intervention for Brain Tumor PatientsRecruitingNCT05976490Not applicable
- Feasibility of Individualized, Model-guided Optimization of Proton Beam Treatment Planning in Patients With Low Grade GliomaRecruitingNCT05964569Phase 2
- Analysis of Circulating DNA in Blood Samples of Glioma-affected PatientsRecruitingNCT05964153Not applicable
- Navigating the Clinical Research Process for GliomaNot yet recruitingNCT05958472
- MRE Evaluation for Spinal Cord Tumor Surgery: Stiffness and Adhesion AssessmentRecruitingNCT05957679Not applicable
- Surgical Tissue Flap to Bypass the Blood Brain Barrier in GlioblastomaRecruitingNCT05954858Not applicable
- Phase 2, Open-label, Single-arm Study on the Use of Metformin as Adjunctive Therapy in High-grade GliomaRecruitingNCT05929495Phase 2
- Multispectral Bimodal Fluorescence Guided Surgery of High-grade Glioma With Cetuximab-800CW and 5-ALA (5-aminolevulinic Acid)RecruitingNCT05929456Phase 1
- A Study to Test How Well Different Doses of BI 764532 Are Tolerated by People With a Tumour in the Brain That is Positive for DLL3RecruitingNCT05916313Phase 1
- Evaluate the Accuracy of Raman IVD Analyzer in the Diagnosis of Gliomas During SurgeryNot yet recruitingNCT05901844Not applicable
- Clinical, patHOlogical and Imaging Project of nEuro-oncology (HOPE)RecruitingNCT05859659
- 5-Aminolevulinic Acid (5-ALA) Gliolan®: Usage Increase Proposal for Neurosurgical Procedures in High-Grade GliomasNot yet recruitingNCT05850377
- Study of Ribociclib and Everolimus in HGG and DIPG or Ribociclib and Temozolomide in DHG, H3G34-mutantRecruitingNCT05843253Phase 2
- Targeted Pediatric High-Grade Glioma TherapyRecruitingNCT05839379
- Window-of-Opportunity Trial of Ulixertinib for MAPK-Activated GliomasRecruitingNCT05804227Early Phase 1
- High-frequency nrTMS on the Contralateral Broca Mirror Area for Glioma Patients With Early Postoperative AphasiaNot yet recruitingNCT05788445Not applicable
- DETERMINE Trial Treatment Arm 03: Entrectinib in Adult, Paediatric and Teenage/Young Adult Patients With ROS1 Gene Fusion-Positive Cancers.RecruitingNCT05770544Phase 2/3
- Study of Liposomal Curcumin in Combination With RT and TMZ in Patients With Newly Diagnosed High-Grade GliomasRecruitingNCT05768919Phase 1/2
- DETERMINE Trial Treatment Arm 05: Vemurafenib in Combination With Cobimetinib in Adult Patients With BRAF Positive Cancers.RecruitingNCT05768178Phase 2/3
- Social Cognition and Language in Patients With GliomasNot yet recruitingNCT05764460
- FUS Etoposide for DMGRecruitingNCT05762419Phase 1
- Safety and Efficacy of Targeted IL-13 Rα2 or B7-H3 UCAR-T for Advanced GliomaRecruitingNCT05752877Not applicable
- MRI-based Computer Aided Diagnosis Software (V1) for GliomaEnrolling by invitationNCT05739500
- Oncolytic Virus Ad-TD-nsIL12 for Primary Pediatric Diffuse Intrinsic Pontine GliomaRecruitingNCT05717712Phase 1
- Oncolytic Virus Ad-TD-nsIL12 for Progressive Pediatric Diffuse Intrinsic Pontine GliomaRecruitingNCT05717699Phase 1
- Intratumoral Extracellular Metabolic Impact of DFMO and AMXT 1501 in Patients With Diffuse or High Grade GliomaRecruitingNCT05717153Early Phase 1
- MRS of Glioma GenomicsRecruitingNCT05700071Not applicable
- A Study of Temodar With Abexinostat (PCI-24781) for Patients With Recurrent GliomaRecruitingNCT05698524Phase 1
- Adenovirus Mediated Suicide Gene Therapy With Radiotherapy in Progressive Astrocytoma.RecruitingNCT05686798Phase 1
- Venous Thromboembolism Prevention in Outpatients With GliomaRecruitingNCT05683808Phase 2
- MeFAMP for Imaging System A Amino Acid Transport in Primary and Metastatic Brain TumorsNot yet recruitingNCT05676489Early Phase 1
- CARv3-TEAM-E T Cells in GlioblastomaRecruitingNCT05660369Phase 1
- Immune and Inflammatory Indices in Peripheral Blood Predict Prognosis of Glioma and Correlate With Grades and SubtypesRecruitingNCT05635435
- Multiparametic Metabolic and Hypoxic PET/MRI for Disease Assessment in High Grade GliomaRecruitingNCT05632562Early Phase 1
- Liquid Biopsy in High-grade Gliomas and MeningiomasRecruitingNCT05630664
- ViCToRy: Vorasidenib in Combination With Tumor Specific Peptide Vaccine for Recurrent IDH1 Mutant Lower Grade GliomasRecruitingNCT05609994Phase 1
- 000860: A Phase I/II Study of Zotiraciclib for Recurrent Malignant Gliomas With Isocitrate Dehydrogenase 1 or 2 (IDH1 or IDH2) MutationsRecruitingNCT05588141Phase 1/2
- ONC201 in H3 K27M-mutant Diffuse Glioma Following Radiotherapy (the ACTION Study)RecruitingNCT05580562Phase 3
- Longitudinal Prospective Study of Neurocognition & Neuroimaging in Primary BT PatientsRecruitingNCT05576103
- Prospective Surgical Study on the Pattern of Electrical Activity in High Grade Glioma as a Predictor of ProgressionRecruitingNCT05565118Phase 1
- A Ketogenic Diet as a Complementary Treatment on Patients With High-grade Gliomas and Brain MetastasesRecruitingNCT05564949Not applicable
- Neoantigens Phase I Trial in Newly Diagnosed Glioblastoma PatientsRecruitingNCT05557240Not applicable
- Mapping of Tumor Stem Cells in the Resection Marigin During Extirpation of Highly Malignant Gliomas Using GlioStemRecruitingNCT05556486
- Evaluation of 18F-Fluciclovine Positron Emission Tomography - Magnetic Resonance Imaging (PET-MRI) in LGGRecruitingNCT05555550Early Phase 1
- 18F-Fluciclovine PET-MRI in High-grade GliomaRecruitingNCT05553041Early Phase 1
- Evaluation of Diagnostic Performances of 18F-FDOPA PET KIneticsRecruitingNCT05512403Phase 3
- Study on Gene Evolution in Glioma Under Stress TherapyNot yet recruitingNCT05512325
- A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF AlterationsRecruitingNCT05503797Phase 2
- Assessment of Compliance With Monitoring Conducted by a Physician in Person or by a Nurse in Remote MonitoringRecruitingNCT05500391Phase 2
- Glioma Developmental and HyperActive Ras Tumor (DHART) BoardRecruitingNCT05489783
- Sonography-guided Resection of Brain Mass LesionsRecruitingNCT05484245Not applicable
- Intraoperative Brain Shift Calculation StudyRecruitingNCT05477680Not applicable
- Concurrent Fluorescence and Sonographically Guided Eradication of High-grade Gliomas and MetastasesRecruitingNCT05474573Not applicable
- Use of CEST (Chemical Exchange Saturation Transfer) Imaging in PET/MRIRecruitingNCT05464992Not applicable
- Safety & Efficacy/Tolerability of Rhenium-186 NanoLiposomes (186RNL) for Patients Who Received a Prior 186RNL TreatmentRecruitingNCT05460507Phase 1
- Study of AZD9574 as Monotherapy and in Combination With Anti-cancer Agents in Participants With Advanced Solid MalignanciesRecruitingNCT05417594Phase 1/2
- Registering Genomics and Imaging of Tumors (ReGIT)RecruitingNCT05386043
- ERC1671 to Treat Malignant Gliomas When Given in Combination With GM-CSF, Cyclophosphamide, Bevacizumab and PembrolizumabNot yet recruitingNCT05366062Phase 2
- Glioblastoma and Individualized TherapiesAvailableNCT05356312
- Effects of Propofol on Auditory Event-related Potentials and Brain Functional Connectivity in Patients With Supratentorial GliomaRecruitingNCT05352685Not applicable
- All-Trans Retinoic Acid (ATRA) Plus PD-1 Inhibition in Recurrent IDH-Mutant GliomaRecruitingNCT05345002Phase 2
- Vacuolar ATPase and Drug Resistance of High Grade GliomasRecruitingNCT05328089
- Tumor Treating Fields for the Treatment of Brainstem GliomasRecruitingNCT05310448Not applicable
- SIGMA (Safusidenib in IDH1 Mutant Glioma Maintenance)RecruitingNCT05303519Phase 3
- GD2-CAR T Cells for Pediatric Brain TumoursRecruitingNCT05298995Phase 1
- Safety Study of the Repeated Opening of the Blood-brain Barrier With the SonoCloud® Device to Treat Malignant Brain Tumors in Pediatric PatientsRecruitingNCT05293197Phase 1
- Lutathera for Treatment of Recurrent or Progressive High-Grade CNS TumorsRecruitingNCT05278208Phase 1/2
- Repeated Superselective Intraarterial Cerebral Infusion (SIACI) of Bevacizumab With Temozolomide and Radiation Compared to Temozolomide and Radiation Alone in Newly Diagnosed GBMRecruitingNCT05271240Phase 3
- Establishing Radiolabelled PSMA as a Target for Glioma TreatmentNot yet recruitingNCT05263466Not applicable
- Observational Study for Assessing Treatment and Outcome of Patients With Primary Brain Tumours Using cIMPACT-NOW and 2021 WHO ClassificationRecruitingNCT05259605
- MRI in High-Grade Glioma Patients Undergoing ChemoradiationRecruitingNCT05212272Not applicable
- Pembrolizumab, Olaparib, and Temozolomide for People With GliomaRecruitingNCT05188508Phase 2
- Evaluation of the CONVIVO SystemRecruitingNCT05139277Not applicable
- PEP-CMV Vaccine Targeting CMV Antigen to Treat Newly Diagnosed Pediatric HGG and DIPG and Recurrent MedulloblastomaRecruitingNCT05096481Phase 2
- Platelets Activation in Brain NeoplasmsRecruitingNCT05049148Not applicable
- Preoperative Radiosurgery for the Treatment of High Grade Glioma, NeoGlioma TrialRecruitingNCT05030298Phase 1